These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32462542)

  • 1. Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration.
    Ashraf MW; Uusalo P; Scheinin M; Saari TI
    Clin Pharmacokinet; 2020 Nov; 59(11):1467-1482. PubMed ID: 32462542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneously administered dexmedetomidine is efficiently absorbed and is associated with attenuated cardiovascular effects in healthy volunteers.
    Uusalo P; Al-Ramahi D; Tilli I; Aantaa RA; Scheinin M; Saari TI
    Eur J Clin Pharmacol; 2018 Aug; 74(8):1047-1054. PubMed ID: 29666901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of dexmedetomidine-induced vasoconstriction in healthy volunteers.
    Talke P; Anderson BJ
    Br J Clin Pharmacol; 2018 Jun; 84(6):1364-1372. PubMed ID: 29495085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects.
    Yoo H; Iirola T; Vilo S; Manner T; Aantaa R; Lahtinen M; Scheinin M; Olkkola KT; Jusko WJ
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1197-207. PubMed ID: 26233335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine.
    Talke P; Richardson CA; Scheinin M; Fisher DM
    Anesth Analg; 1997 Nov; 85(5):1136-42. PubMed ID: 9356115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.
    Scheinin H; Aantaa R; Anttila M; Hakola P; Helminen A; Karhuvaara S
    Anesthesiology; 1998 Sep; 89(3):574-84. PubMed ID: 9743392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
    Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
    J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine Clearance Decreases with Increasing Drug Exposure: Implications for Current Dosing Regimens and Target-controlled Infusion Models Assuming Linear Pharmacokinetics.
    Alvarez-Jimenez R; Weerink MAS; Hannivoort LN; Su H; Struys MMRF; Loer SA; Colin PJ
    Anesthesiology; 2022 Feb; 136(2):279-292. PubMed ID: 34851425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects.
    Snapir A; Posti J; Kentala E; Koskenvuo J; Sundell J; Tuunanen H; Hakala K; Scheinin H; Knuuti J; Scheinin M
    Anesthesiology; 2006 Nov; 105(5):902-10; quiz 1069-70. PubMed ID: 17065883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers.
    Dyck JB; Maze M; Haack C; Vuorilehto L; Shafer SL
    Anesthesiology; 1993 May; 78(5):813-20. PubMed ID: 8098190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine.
    Weerink MAS; Struys MMRF; Hannivoort LN; Barends CRM; Absalom AR; Colin P
    Clin Pharmacokinet; 2017 Aug; 56(8):893-913. PubMed ID: 28105598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers.
    Dyck JB; Maze M; Haack C; Azarnoff DL; Vuorilehto L; Shafer SL
    Anesthesiology; 1993 May; 78(5):821-8. PubMed ID: 8098191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine.
    Li A; Yuen VM; Goulay-Dufaÿ S; Sheng Y; Standing JF; Kwok PCL; Leung MKM; Leung AS; Wong ICK; Irwin MG
    Br J Anaesth; 2018 May; 120(5):960-968. PubMed ID: 29661413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, cortisol release, and hemodynamics after intravenous and subcutaneous injection of human corticotropin-releasing factor in humans.
    Angst MS; Dyck JB; Azarnoff DL; Goldblum R; Ho B; Gfroerer T; Linton EA; Glynn BP; Shafer SL
    Clin Pharmacol Ther; 1998 Nov; 64(5):499-510. PubMed ID: 9834042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine hemodynamics in children after cardiac surgery.
    Potts AL; Anderson BJ; Holford NH; Vu TC; Warman GR
    Paediatr Anaesth; 2010 May; 20(5):425-33. PubMed ID: 20337956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamic effects of oral transmucosal and intravenous administration of dexmedetomidine in dogs.
    Dent BT; Aarnes TK; Wavreille VA; Lakritz J; Lerche P; KuKanich B; Riccó Pereira CH; Bednarski RM
    Am J Vet Res; 2019 Oct; 80(10):969-975. PubMed ID: 31556717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics of Dexmedetomidine After Short Intravenous Infusion in Chinese Children.
    Liu HC; Lian QQ; Wu FF; Wang CY; Sun W; Zheng LD; Schüttler J; Ihmsen H
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):201-211. PubMed ID: 27037817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
    Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
    Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients.
    Iirola T; Ihmsen H; Laitio R; Kentala E; Aantaa R; Kurvinen JP; Scheinin M; Schwilden H; Schüttler J; Olkkola KT
    Br J Anaesth; 2012 Mar; 108(3):460-8. PubMed ID: 22277665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of increasing plasma concentrations of dexmedetomidine in humans.
    Ebert TJ; Hall JE; Barney JA; Uhrich TD; Colinco MD
    Anesthesiology; 2000 Aug; 93(2):382-94. PubMed ID: 10910487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.